DNA test links genes to suicide in antidepressant users

Print Friendly, PDF & Email

When a patient first begins to take antidepressants, there is actually a chance that person may commit suicide within the first two weeks — it’s known as medication-induced suicide.

The risk increases during this recovery period, and scientists have not known why in the past. According to the Max Planck Institute of Psychiatry, 59 percent of patients committed suicide within two weeks of initial treatment, and 8 percent experienced the adverse effects of medication when they first began taking them.

The company Sundance Diagnostics plans to enter a licensing agreement with the Max Planck Institute of Psychiatry to bring a new suicidality test into the market. The suicidality test would be able to identify a person’s suicide risk based on certain gene markers.

Read the full, original story: New ‘Suicidality’ Test Predicts Antidepressant-Induced Suicide Risk In Patients

Outbreak Featured
Infographic: Autoimmune diseases — 76 identified so far — tend to target women over men. Here is a master list

Infographic: Autoimmune diseases — 76 identified so far — tend to target women over men. Here is a master list

There are many autoimmune diseases, and taken together they affect as much as 4.5 percent of the world’s population. This ...
Are GMOs and pesticides threatening bees?

Are GMOs and pesticides threatening bees?

First introduced in 1995, neonicotinoids ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.